Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

被引：1
|
作者：
Leisti, Paivi [1 ,2 ]
Pankakoski, Anna [3 ,4 ]
Jokelainen, Jari [5 ]
Huilaja, Laura [1 ,2 ]
Panelius, Jaana [3 ,4 ]
Tasanen, Kaisa [1 ,2 ]
Varpuluoma, Outi [1 ,2 ]
机构：
[1] Oulu Univ Hosp, Med Res Ctr Oulu, Dept Dermatol, Res Unit Clin Med, Aapistie 5 A, FIN-90220 Oulu, Finland
[2] Univ Oulu, Aapistie 5 A, Oulu 90220, Finland
[3] Univ Helsinki, Dept Dermatol & Allergol, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Univ Oulu, Infrastruct Populat Studies, Oulu, Finland
来源：
ACTA DERMATO-VENEREOLOGICA | 2024年 / 104卷
基金：
芬兰科学院;
关键词：
D O I：
10.2340/actadv.v104.40645
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Bullous Pemphigoid Associated With Linagliptin Treatment
    Haber, Roger
    Fayad, Alice Mouna
    Stephan, Farid
    Obeid, Grace
    Tomb, Roland
    JAMA DERMATOLOGY, 2016, 152 (02) : 224 - 226
  • [2] Bullous pemphigoid associated with linagliptin treatment in diabetic patients with chronic kidney disease
    Sanchez Lopez-Muelas, Belen
    Muray Cases, Salome
    Illan Gomez, Fatima
    Garcia Guzman, Gloria
    Arjonilla Sampedro, Maria Elena
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (05): : 338 - 339
  • [3] Linagliptin-associated bullous pemphigoid treated with rituximab
    Mani, Hariharasudan
    Safo, Patrick
    Onitilo, Adedayo A.
    BMJ CASE REPORTS, 2019, 12 (09)
  • [4] Linagliptin treatment-associated bullous pemphigoid presenting severe mucosal erosions
    Mukaijo, Junko
    Kanaoka, Miwa
    Kawano, Katsuyuki
    Matsukura, Setsuko
    Hibiya, Takashi
    Miyake, Akio
    Izumi, Kentaro
    Nishie, Wataru
    Shimizu, Hiroshi
    Aihara, Michiko
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2018, 1 (02) : 77 - 78
  • [5] Linagliptin-Associated Bullous Pemphigoid: The First Case in China
    Liu Yang-Chun
    Zhao Wen-Ling
    Li Li
    国际皮肤性病学杂志（英文）, 2020, 03 (02) : 113 - 115
  • [6] Management Of Bullous Pemphigoid with Diabetes Mellitus Type 2
    Palsapure, Pratiksha S.
    Balpande, Vaishali
    Pathade, Aniket
    Narlawar, M. S.
    Gujar, samruddhi
    INTERNATIONAL JOURNAL OF EARLY CHILDHOOD SPECIAL EDUCATION, 2022, 14 (04) : 2304 - 2307
  • [7] Linagliptin for the treatment of type 2 diabetes
    Del Prato, Stefano
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (17) : 2759 - 2762
  • [8] Bullous Pemphigoid Associated with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Type 2 Diabetes: A Multicenter Study in Istanbul
    Ugurer, Ece
    Ozkur, Ezgi
    Altunay, Ilknur Kivanc
    Sen, Esra Cil
    Aksu, Ayse Esra Koku
    Ozcan, Ilknur
    Altuntas, Yuksel
    Gurel, Mehmet Salih
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2022, 56 (03): : 375 - 380
  • [9] Two cases of linagliptin-associated bullous pemphigoid resulting in sepsis and endocarditis
    Vanner, Michael
    Tanner, Alexander
    Chakera, Ali
    BMJ CASE REPORTS, 2024, 17 (02)
  • [10] Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil
    Sakanoue, Masanao
    Kawai, Kazuhiro
    Kanekura, Takuro
    JOURNAL OF DERMATOLOGY, 2012, 39 (10): : 884 - 885
12345